title: Guidelines for hormone treatment of women in the menopausal transition and beyond.
authors.forename: F
authors.initials: F
authors.lastname: Naftolin
authors.forename: H P G
authors.initials: HP
authors.lastname: Schneider
authors.forename: D W
authors.initials: DW
authors.lastname: Sturdee
authors.forename: M
authors.initials: M
authors.lastname: Birkhäuser
authors.forename: M P
authors.initials: MP
authors.lastname: Brincat
authors.forename: M
authors.initials: M
authors.lastname: Gambacciani
authors.forename: A R
authors.initials: AR
authors.lastname: Genazzani
authors.forename: K K
authors.initials: KK
authors.lastname: Limpaphayom
authors.forename: S
authors.initials: S
authors.lastname: O'Neill
authors.forename: S
authors.initials: S
authors.lastname: Palacios
authors.forename: A
authors.initials: A
authors.lastname: Pines
authors.forename: N
authors.initials: N
authors.lastname: Siseles
authors.forename: D
authors.initials: D
authors.lastname: Tan
authors.forename: H G
authors.initials: HG
authors.lastname: Burger
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D016889:Endometrial Neoplasms / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000592:standards*; D005260:Female; D006801:Humans; D008593:Menopause / Q000502:physiology*; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic